[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353011-105":59,"doc-detail-353011-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","prognostic-significance-and-immune-correlation-of-sting-expression-and-promoter-methylation-in-renal-cell-carcinoma","Prognostic significance and immune correlation of STING expression and promoter methylation in renal cell carcinoma","","Renal cell carcinoma (RCC) shows resistance to immunotherapy and poor outcomes, and the role of DNA methylation in shaping immune infiltration remains unclear. This study links STING promoter methylation with mRNA expression, overall survival, and immune cell infiltration using TCGA data, an independent validation cohort, and an RCC cohort from SYSUCC assessed by immunohistochemistry and pyrosequencing. Hypomethylation correlated with higher STING expression, advanced features, worse survival, and increased immune checkpoint molecule expression, including CD4/CD8 T-cell infiltration, suggesting a potential biomarker for predicting response to immune checkpoint inhibitors.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prognostic-significance-and-immune-correlation-of-sting-expression-and-promoter-methylation-in-renal-cell-carcinoma/353011/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prognostic-significance-and-immune-correlation-of-sting-expression-and-promoter-methylation-in-renal-cell-carcinoma/353011.png","ImageObject",300,407,{"name":92,"@type":93},"Stanford","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How was the relationship between STING promoter methylation and immune activity evaluated?","Question",{"text":112,"@type":113},"The study analyzed STING promoter methylation and STING mRNA expression across TCGA and an independent cohort, then validated correlations in an SYSUCC RCC cohort using immunohistochemistry and pyrosequencing.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What does the study report about STING promoter methylation in RCC tumors compared with normal tissues?",{"text":117,"@type":113},"STING promoter hypomethylation was significant in RCC tumor tissues versus normal tissues.",{"name":119,"@type":110,"acceptedAnswer":120},"What clinical relevance is suggested by STING promoter methylation?",{"text":121,"@type":113},"The results associate STING promoter methylation with clinicopathological characteristics, overall survival, and immune cell infiltration, proposing its use as a biomarker to predict responses to immune checkpoint inhibitors in RCC.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},353011,1790143543,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336477552062,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nPrognostic significance and immune correlation of STING expression and promoter methylation in renal cell carcinoma  \nShirong Ding1,4, Mengge Ding1, Ao’ran Hu1, Yishu Guo1, Qi Meng4, KunYe5, Min Lu1, Chaoyuan Liu1, Fang Ma1, Qian Long2,4􀀍 & Xianling Liu1,3􀀍  \nRenal cell carcinoma (RCC) typically shows resistance to immunotherapy and is associated with poor prognosis. Recent studies have revealed a role for DNA methylation in immune infiltration in different cancers, but its pattern in RCC is not well understood. In this study, we analyzed the relationships among STING promoter methylation, mRNA expression, overall survival, and immune cell infiltration in a TCGA cohort and validated the findings in an independent cohort. Additionally, we assessed these correlations in an RCC cohort from SunYat-sen University Cancer Center (SYSUCC) using immunohistochemistry and pyrosequencing. Our findings revealed significant hypomethylation of the STING promoter in RCC tumor tissues compared with normal tissues, which strongly correlated with increased STING mRNA expression across all three RCC cohorts. Additionally, hypomethylation of the STING promoter hypomethylation was associated with advanced clinicopathological features and poor overall survival. Moreover, we found a significant relationship between STING promoter methylation and both immune cell infiltration and the expression of immune checkpoint molecules. Our findingsin the SYSUCC cohort confirmed that STING promoter methylation was related to CD4 and CD8 T-cell infiltration in RCC tumor tissues. These results suggest that methylation of the STING promoter plays a pivotal role in regulating its expression and influencing the tumor microenvironment. STING promoter methylation and expression are linked to clinicopathological characteristics, overall survival, and immune cell infiltration in RCC. We propose that further validation of STING promoter methylation represents a biomarker for predicting responses to immune checkpoint inhibitors in RCC.  \nKeywords DNA methylation, Epigenetics, Biomarker, STING, Renal cell carcinoma, Tumor immune microenvironment  \nRenal cell carcinoma (RCC) is the most prevalent form of kidney cancer, constituting 4.1% of all newly diagnosed cancer cases in the United States in 20221. RCC encompasses primarily clear-cell RCC (70–80%), along with papillary RCC and chromophobe RCC2. Although early-stage RCC is typically managed surgically, nearly 30% of patients eventually develop recurrence or distant metastasis3,4. Historically perceived as a “hot” cancer, RCC displays notable immunogenicity coupled with significant infiltration of immune cells5. These biological characteristics support the clinical success of immunotherapy, particularly immune checkpoint blockade (ICB), in reshaping RCC treatment paradigms6,7. Current first-line approaches integrate immune checkpoint blockade (ICB) with tyrosine kinase inhibitors8,9. However, immune infiltration often induces compensatory upregulation of immune checkpoint molecules, reinforcing an immunosuppressive tumor microenvironment (TME) that limits sustained antitumor responses10. Although a subset of patients experience durable clinical benefits from ICB, primary and acquired resistance remains common, restricting its broader clinical impact11. Hence,  \n1Department of Oncology, The Second Xiangya Hospital of Central South University, 139 Middle Renmin Road, Changsha 410011, China. 2Department of General Surgery, The Second Xiangya Hospital of Central South University, 139 Middle Renmin Road, Changsha 410011, China. 3Department of Oncology, Guilin Hospital of the Second Xiangya Hospital, Central South University, Guilin, China. 4Department of Clinical Research, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, SunYat-sen University, Guangzhou, ","cbCaiq2SMYExFDfW","https://ap.wps.com/l/cbCaiq2SMYExFDfW","pdf",7254905,15,"English","# Background\n## RCC and immune checkpoint therapy\n## STING and the cGAS–STING pathway\n## DNA methylation and immune infiltration\n# Study Design and Cohorts\n## TCGA analysis\n## Independent validation\n## SYSUCC cohort methods\n# Key Findings\n## STING promoter hypomethylation in RCC\n## Association with STING mRNA expression\n## Links to clinicopathological features and survival\n## Correlation with immune infiltration and checkpoint molecules\n# Implications","[{\"question\":\"How was the relationship between STING promoter methylation and immune activity evaluated?\",\"answer\":\"The study analyzed STING promoter methylation and STING mRNA expression across TCGA and an independent cohort, then validated correlations in an SYSUCC RCC cohort using immunohistochemistry and pyrosequencing.\"},{\"question\":\"What does the study report about STING promoter methylation in RCC tumors compared with normal tissues?\",\"answer\":\"STING promoter hypomethylation was significant in RCC tumor tissues versus normal tissues.\"},{\"question\":\"What clinical relevance is suggested by STING promoter methylation?\",\"answer\":\"The results associate STING promoter methylation with clinicopathological characteristics, overall survival, and immune cell infiltration, proposing its use as a biomarker to predict responses to immune checkpoint inhibitors in RCC.\"}]","Prognostic significance and immune correlation of STING expression and promoter methylation in renal cell carcinoma | PDF",1790102552,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8a1aacfee298e23fca423d8e33a15599.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0959c318f4a06adf40cbfd999e47acfd.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c662ead391e45922df6fd6d1b4bddc58.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ab5c60ce39a856a2482d018d880325e0.webp",980,1287]